Ranisan 150 mg apvalkotās tabletes Letonya - Letonca - Zāļu valsts aģentūra

ranisan 150 mg apvalkotās tabletes

pro.med.cs praha a.s., czech republic - ranitidīns - apvalkotā tablete - 150 mg

Prindal 4 mg/1,25 mg/5 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

prindal 4 mg/1,25 mg/5 mg tabletes

zentiva, k.s., czech republic - tert-butylamini perindoprilum, indapamidum, amlodipinum - tablete - 4 mg/1,25 mg/5 mg

Prindal 4 mg/1,25 mg/10 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

prindal 4 mg/1,25 mg/10 mg tabletes

zentiva, k.s., czech republic - tert-butylamini perindoprilum, indapamidum, amlodipinum - tablete - 4 mg/1,25 mg/10 mg

Prindal 8 mg/2,5 mg/5 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

prindal 8 mg/2,5 mg/5 mg tabletes

zentiva, k.s., czech republic - tert-butylamini perindoprilum, indapamidum, amlodipinum - tablete - 8 mg/2,5 mg/5 mg

Prindal 8 mg/2,5 mg/10 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

prindal 8 mg/2,5 mg/10 mg tabletes

zentiva, k.s., czech republic - tert-butylamini perindoprilum, indapamidum, amlodipinum - tablete - 8 mg/2,5 mg/10 mg

Enalapril Polpharma 5 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

enalapril polpharma 5 mg tabletes

zaklady farmaceutyczne polpharma s.a., poland - enalaprila maleāts - tablete - 5 mg

Enalapril Polpharma 10 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

enalapril polpharma 10 mg tabletes

zaklady farmaceutyczne polpharma s.a., poland - enalaprila maleāts - tablete - 10 mg

Enalapril Polpharma 20 mg tabletes Letonya - Letonca - Zāļu valsts aģentūra

enalapril polpharma 20 mg tabletes

zaklady farmaceutyczne polpharma s.a., poland - enalaprila maleāts - tablete - 20 mg

Axura Avrupa Birliği - Letonca - EMA (European Medicines Agency)

axura

merz pharmaceuticals gmbh - memantīna hidrohlorīds - alcheimera slimība - other anti-dementia drugs - pacientiem ar vidēji smagu vai smagu alcheimera slimību ārstēšana.

BiResp Spiromax Avrupa Birliği - Letonca - EMA (European Medicines Agency)

biresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - zāles obstruktīvu elpceļu slimību, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).